RSS-Feed abonnieren
DOI: 10.1055/s-0043-117892
Hashimoto’s Thyroiditis is an Important Risk Factor of Papillary Thyroid Microcarcinoma in Younger Adults
Publikationsverlauf
received 24. Februar 2017
accepted 24. Juli 2017
Publikationsdatum:
31. August 2017 (online)
Abstract
The association between autoimmune thyroid disease and thyroid cancer remains unclear. We performed a matched case-control study to assess the association between Hashimoto’s thyroiditis and papillary thyroid microcarcinoma (PTMC). A total of 927 PTMC cases and 927 age- and gender- matched controls selected from the same population were recruited. Odds ratio (OR) with 95% confidence interval (95% CI) was used to assess the strength of the association between Hashimoto’s thyroiditis and PTMC. Conditional logistic regression analysis was carried out, and stratified analyses by age, gender and types of thyroid antibodies were also performed. Hashimoto’s thyroiditis was significantly associated with increased risk of PTMC (OR=1.87, 95% CI 1.49–2.34, p<0.001). Stratified analysis by thyroid antibodies also found obvious associations of PTMC risk with TPOAb positivity (OR=1.58, p=0.001) and TGAb positivity (OR=2.35, p<0.001). Stratified analyses by age showed that the association between Hashimoto’s thyroiditis and PTMC risk was more significant in younger adults aged between 18 and 30 years (OR=11.48, p<0.001). Further stratified analyses by thyroid antibodies also found that the associations of PTMC risk with TPOAb positivity or TGAb positivity were more significant in younger adults aged between 18 and 30, and the ORs were 8.27 (p<0.001) and 12.71 (p<0.001), respectively. This study suggests an obvious relationship between Hashimoto’s thyroiditis and PTMC risk, and Hashimoto’s thyroiditis is an important risk of PTMC in younger adults.
-
References
- 1 Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin 2017; 67: 7-30
- 2 Morris LG, Tuttle RM, Davies L. Changing trends in the incidence of thyroid cancer in the united states. JAMA Otolaryngol Head Neck Surg 2016; 142: 709-711
- 3 Londero SC, Krogdahl A, Bastholt L, Overgaard J, Trolle W, Pedersen HB, Bentzen J, Schytte S, Christiansen P, Godballe C. Papillary thyroid microcarcinoma in Denmark 1996-2008: A national study of epidemiology and clinical significance. Thyroid 2013; 23: 1159-1164
- 4 Cabanillas ME, McFadden DG, Durante C. Thyroid cancer. Lancet 2016; 388: 2783-2795
- 5 Pacini F. Thyroid microcarcinoma. Best Pract Res Clin Endocrinol Metab 2012; 26: 381-389
- 6 Soares P, Celestino R, Gaspar da Rocha A, Sobrinho-Simoes M. Papillary thyroid microcarcinoma: how to diagnose and manage this epidemic?. Int J Surg Pathol 2014; 22: 113-119
- 7 Leidig-Bruckner G, Bruckner T, Raue F, Frank-Raue K. long-term follow-up and treatment of postoperative permanent hypoparathyroidism in patients with medullary thyroid carcinoma: Differences in complete and partial disease. Horm Metab Res 2016; 48: 806-813
- 8 Rosario PW, Calsolari MR. Usefulness of serum calcitonin in patients without a suspicious history of medullary thyroid carcinoma and with thyroid nodules without an indication for fine-needle aspiration or with benign cytology. Horm Metab Res 2016; 48: 372-376
- 9 Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P. Autoimmune thyroid disorders. Autoimmun Rev 2015; 14: 174-180
- 10 McLeod DS, Caturegli P, Cooper DS, Matos PG, Hutfless S. Variation in rates of autoimmune thyroid disease by race/ethnicity in US military personnel. JAMA 2014; 311: 1563-1565
- 11 Banga JP, Schott M. Autoimmune Thyroid Diseases. Horm Metab Res 2015; 47: 699-701
- 12 McLeod DS, Cooper DS. The incidence and prevalence of thyroid autoimmunity. Endocrine 2012; 42: 252-265
- 13 Moreno-Reyes R, Glinoer D, Van Oyen H, Vandevijvere S. High prevalence of thyroid disorders in pregnant women in a mildly iodine-deficient country: A population-based study. J Clin Endocrinol Metab 2013; 98: 3694-3701
- 14 Ajjan RA, Weetman AP. The pathogenesis of hashimoto's thyroiditis: Further developments in our understanding. Horm Metab Res 2015; 47: 702-710
- 15 Rostamzadeh D, Dabbaghmanesh MH, Shabani M, Hosseini A, Amirghofran Z. Expression Profile of Human Fc Receptor-Like 1, 2, and 4 Molecules in peripheral blood mononuclear cells of patients with Hashimoto's Thyroiditis and Graves' disease. Horm Metab Res 2015; 47: 693-698
- 16 Sarkhail P, Mehran L, Askari S, Tahmasebinejad Z, Tohidi M, Azizi F. Maternal thyroid function and autoimmunity in 3 trimesters of pregnancy and their offspring's thyroid function. Horm Metab Res 2016; 48: 20-26
- 17 Karch A, Thomas SL. Autoimmune thyroiditis as a risk factor for stroke: a historical cohort study. Neurology 2014; 82: 1643-1652
- 18 Zoller B, Li X, Sundquist J, Sundquist K. Risk of subsequent coronary heart disease in patients hospitalized for immune-mediated diseases: A nationwide follow-up study from Sweden. PLoS One 2012; 7: e33442
- 19 Topaloglu O, Gokay F, Kucukler K, Burnik FS, Mete T, Yavuz HC, Berker D, Guler S. Is autoimmune thyroiditis a risk factor for early atherosclerosis in premenopausal women even if in euthyroid status?. Endocrine 2013; 44: 145-151
- 20 Fontenelle LC, Feitosa MM, Severo JS, Freitas TE, Morais JB, Torres-Leal FL, Henriques GS, do Nascimento Marreiro D. Thyroid function in human obesity: Underlying mechanisms. Horm Metab Res 2016; 48: 787-794
- 21 Azizi G, Keller JM, Lewis M, Piper K, Puett D, Rivenbark KM, Malchoff CD. Association of Hashimoto's thyroiditis with thyroid cancer. Endocr Relat Cancer 2014; 21: 845-852
- 22 Noureldine SI, Tufano RP. Association of Hashimoto's thyroiditis and thyroid cancer. Curr Opin Oncol 2015; 27: 21-25
- 23 Benvenga S. On the association between Hashimoto's thyroiditis and papillary thyroid carcinoma: Looking 100 years back and, hopefully, fewer years ahead to sort out this association. Thyroid 2013; 23: 1180-1181
- 24 Dvorkin S, Robenshtok E, Hirsch D, Strenov Y, Shimon I, Benbassat CA. Differentiated thyroid cancer is associated with less aggressive disease and better outcome in patients with coexisting Hashimotos thyroiditis. J Clin Endocrinol Metab 2013; 98: 2409-2414
- 25 Fukuda A, Hirohata T, Noguchi S, Ikeda M, Matsuo K, Yoshida A. Risks for malignancies in patients with chronic thyroiditis: A long-term follow-up study. Jpn J Cancer Res 1987; 78: 1329-1334
- 26 Liu CL, Cheng SP, Lin HW, Lai YL. Risk of thyroid cancer in patients with thyroiditis: A population-based cohort study. Ann Surg Oncol 2014; 21: 843-849
- 27 Holm LE, Blomgren H, Lowhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 1985; 312: 601-604
- 28 Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L. 2015; American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016; 26: 1-133
- 29 Mintziori G, Adamidou F, Kita M. Hashimoto's thyroiditis and papillary thyroid cancer: Polyglandular hints. Trends Endocrinol Metab 2015; 26: 395
- 30 Paparodis R, Imam S, Todorova-Koteva K, Staii A, Jaume JC. Hashimoto's thyroiditis pathology and risk for thyroid cancer. Thyroid 2014; 24: 1107-1114
- 31 Ehlers M, Schott M. Hashimoto's thyroiditis and papillary thyroid cancer: are they immunologically linked?. Trends Endocrinol Metab 2014; 25: 656-664
- 32 Jankovic B, Le KT, Hershman JM. Clinical Review: Hashimoto's thyroiditis and papillary thyroid carcinoma: is there a correlation?. J Clin Endocrinol Metab 2013; 98: 474-482
- 33 Anil C, Goksel S, Gursoy A. Hashimoto's thyroiditis is not associated with increased risk of thyroid cancer in patients with thyroid nodules: A single-center prospective study. Thyroid 2010; 20: 601-606
- 34 Fiore E, Rago T, Latrofa F, Provenzale MA, Piaggi P, Delitala A, Scutari M, Basolo F, Di Coscio G, Grasso L, Pinchera A, Vitti P. Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: Role of TSH and of treatment with l-thyroxine. Endocr Relat Cancer 2011; 18: 429-437
- 35 Loh KC, Greenspan FS, Dong F, Miller TR, Yeo PP. Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 1999; 84: 458-463
- 36 Mechler C, Bounacer A, Suarez H, Saint Frison M, Magois C, Aillet G, Gaulier A. Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements. Br J Cancer 2001; 85: 1831-1837
- 37 Maceri DR, Sullivan MJ, McClatchney KD. Autoimmune thyroiditis: pathophysiology and relationship to thyroid cancer. Laryngoscope 1986; 96: 82-86
- 38 Koibuchi H, Omoto K, Fukushima N, Toyotsuji T, Taniguchi N, Kawano M. Coexistence of papillary thyroid cancer and Hashimoto thyroiditis in children: report of 3 cases. J Ultrasound Med 2014; 33: 1299-1303
- 39 Snyder EM, Nicol KK, Buchan A, Coley BD. Synchronous presentation of Hashimoto thyroiditis and papillary thyroid carcinoma in a 7-year-old girl. J Ultrasound Med 2010; 29: 1007-1010
- 40 Okani CO, Otene B, Nyaga T, Ngbea J, Eke A, Edegbe F, Anyiam D. Report of a case of papillary thyroid carcinoma in association with Hashimoto's thyroiditis. Niger Med J 2015; 56: 433-435
- 41 Karavanaki K, Karayianni C, Vassiliou I, Tzanela M, Sdogou T, Kakleas K, Tsentidis C, Vakaki M, Soldatou A, Kallinikou D, Kostaki M, Tsitsopoulos S, Papathanasiou A. Multiple autoimmunity, type 1 diabetes (T1DM), autoimmune thyroiditis and thyroid cancer: Is there an association? A case report and literature review. J Pediatr Endocrinol Metab 2014; 27: 1011-1016